India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
AI Isn't Ready to Make Unsupervised Decisions
It is important to recognize that artificial intelligence (AI) is not yet capable of making unsupervised decisions. While AI has made significant progress in a wide range of areas, it is still limited in its ability to understand and interpret complex situations and make informed decisions without human oversight.
One reason for this is that AI systems are only as good as the data they are based on. If the data is biased or incomplete, the decisions made by the AI system may also be biased or inaccurate. Additionally, AI systems may not have the same level of understanding and context as humans, which can limit their ability to make informed decisions.
Another reason is that AI systems are vulnerable to manipulation and can be exploited by malicious actors. For example, an AI system might be fed biased or misleading data in order to influence its decisions.
Overall, it is important to recognize that AI is not yet ready to make unsupervised decisions and to use it in a way that is appropriate and responsible. This may involve providing oversight and guidance, as well as putting in place appropriate safeguards and controls. It's also important to continue to invest in the development and advancement of AI technology, in order to improve its capabilities and increase its potential value.
Artificial intelligence (AI) has the potential to make significant contributions in a wide range of fields, including finance, healthcare, and transportation. However, it is important to recognize that AI is not yet ready to make unsupervised decisions, and that it is important to carefully consider the limitations of AI and to use it in conjunction with human expertise and judgment.
One of the main limitations of AI is that it is only as good as the data it is based on. If the data is biased or incomplete, the results produced by the AI may also be biased or misleading. Additionally, AI algorithms can be difficult to understand and interpret, making it challenging to fully understand how they arrived at a particular decision.
Another limitation of AI is that it lacks the ability to understand context and nuance in the same way that humans can. This can make it difficult for AI to fully understand the implications of a particular decision or to recognize when a situation requires a more complex or creative approach.
Overall, it's important to recognize that AI is not yet ready to make unsupervised decisions, and that it is important to carefully consider the limitations of AI and to use it in conjunction with human expertise and judgment.
Comments
Post a Comment
If you have any doubts. Please let me know.